SAR292833

· Sanofi

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SAR292833, covering 2016-02-26 to 2016-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain [Phase 2]

See pricing